Cargando…
Complicated ventricular arrhythmia and hematologic myeloproliferative disorder in RIT1‐associated Noonan syndrome: Expanding the phenotype and review of the literature
BACKGROUND: Noonan syndrome is an autosomal dominant disorder secondary to RASopathies, which are caused by germ‐line mutations in genes encoding components of the RAS mitogen‐activated protein kinase pathway. RIT1 (OMIM *609591) was recently reported as a disease gene for Noonan syndrome. METHODS A...
Autores principales: | Aly, Safwat A., Boyer, Kenneth M., Muller, Brie‐Ann A., Marini, Davide, Jones, Carolyn H., Nguyen, Hoang H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336743/ https://www.ncbi.nlm.nih.gov/pubmed/32396283 http://dx.doi.org/10.1002/mgg3.1253 |
Ejemplares similares
-
A novel RIT1 mutation causes deterioration of Noonan syndrome-associated cardiac hypertrophy
por: Cai, Jingjing, et al.
Publicado: (2019) -
Noonan syndrome caused by RIT1 gene mutation: A case report and literature review
por: Zha, Ping, et al.
Publicado: (2022) -
Dilated coronary arteries in a 2-month-old with RIT1-associated Noonan syndrome: a case report
por: Aniol, Claudia V., et al.
Publicado: (2023) -
RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome–associated cardiac hypertrophy
por: Cuevas-Navarro, Antonio, et al.
Publicado: (2023) -
New Noonan syndrome model mice with RIT1 mutation exhibit cardiac hypertrophy and susceptibility to β-adrenergic stimulation-induced cardiac fibrosis
por: Takahara, Shingo, et al.
Publicado: (2019)